SECURITIES FRAUD LAWSUIT FILED: CytomX Therapeutics, Inc. Sued for Securities Fraud; Investors Who Have Lost Money Should Contact Block & Leviton LLP

In this article:

BOSTON, MA / ACCESSWIRE / May 21, 2020 / Block & Leviton LLP (www.blockesq.com), a national securities litigation firm, announces that a securities fraud lawsuit has been filed against CytomX Therapeutics, Inc. (CTMX) and certain of its officers. Investors who have lost money are encouraged to contact the firm for a free case evaluation.

CytomX is a biopharmaceutical company in the U.S. Two of its lead product candidates are known as CX-072 and CX-2009, both of which are being evaluated to treat cancer. The lawsuit, filed in the U.S. District Court for the Northern District of California, alleges that between 2018 and 2020, CytomX misled investors concerning the efficacy of both product candidates, as well as concerning safety issues regarding CX-2009.

Then, on May 13, 2020, after the markets closed, CytomX made available abstracts of the Company's clinical presentations for CX-072 and CX-2009. The lawsuit alleges that these abstracts revealed the truth about the alleged efficacy and safety issues plaguing these product candidates. On May 14, 2020, the price of CytomX common stock fell over 36%.

If you purchased or acquired shares of CytomX between May 17, 2018 and May 13, 2020, have lost money as a result of these announcements, and have questions about your legal rights or possess information relevant to this matter, please contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockesq.com, or at https://shareholder.law/cytomx.

Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the country's financial markets. The firm represents many of the nation's largest institutional investors as well as individual investors in securities litigation throughout the United States. The firm's lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: cases@blockesq.com
SOURCE: Block & Leviton LLP
www.blockesq.com

SOURCE: Block & Leviton LLP



View source version on accesswire.com:
https://www.accesswire.com/590919/SECURITIES-FRAUD-LAWSUIT-FILED-CytomX-Therapeutics-Inc-Sued-for-Securities-Fraud-Investors-Who-Have-Lost-Money-Should-Contact-Block-Leviton-LLP

Advertisement